Buy PREVYMIS 240 mg/1 LETERMOVIR

Prevymis 240 mg is an antiviral medication used to prevent cytomegalovirus (CMV) infections in adults. This oral tablet is commonly prescribed for transplant patients to reduce the risk of CMV reactivation.

Strength

240 mg/1

Pack Size

4 DOSE PACK in 1 CARTON (0006-3075-02) / 7 TABLET, FILM COATED in 1 DOSE PACK (0006-3075-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Prevymis 240 mg is primarily used for the prevention of cytomegalovirus (CMV) infections. It is often prescribed to individuals who have undergone organ transplants, as they are at a higher risk of CMV reactivation. This medication works by targeting the virus to help manage and prevent CMV-related complications. People often search for 'Prevymis uses' or 'what is Prevymis used for' to understand its role in antiviral therapy.

Side Effects

Common effects of Prevymis 240 mg may include gastrointestinal issues such as nausea, diarrhea, and vomiting. Some individuals might experience fatigue or headaches. These effects can vary in intensity and duration, and it's important to monitor any persistent or severe symptoms.

Precautions & Warnings

Prevymis 240 mg should be handled with care, following the prescribed dosage and administration guidelines. It is essential to inform healthcare providers about any existing medical conditions or allergies before starting this medication. Proper storage and handling are crucial to maintain the effectiveness of the tablets.

Avoid Interactions

Prevymis 240 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to consult a healthcare provider before combining Prevymis with other medications, especially those known to interact with antiviral drugs. Alcohol consumption should also be discussed with a healthcare professional.

References

Frequently Asked Questions

Prevymis is used to prevent cytomegalovirus (CMV) infections, particularly in transplant patients at risk of CMV reactivation.

Prevymis is taken orally, typically as a film-coated tablet. The specific dosage and duration should be determined by a healthcare provider.

Common side effects may include nausea, diarrhea, vomiting, fatigue, and headaches. These effects can vary in severity.

Prevymis may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Prevymis should be used under the guidance of a healthcare provider, especially for individuals with pre-existing medical conditions or allergies.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.